Table 4.
The clinicopathologic characteristics of the validation set patients
| Early recurrence (TTR ≤ 10 months) | Late recurrence (TTR > 10 months) | |
|---|---|---|
| Number of cases | 72 | 70 |
| Median age (years) | 58 | 55 |
| Staging | ||
| Stage III | 63 | 62 |
| Stage IV | 9 | 8 |
| Histological type | ||
| Serous adenocarcinoma | 60 | 51 |
| Mucinous adenocarcinoma | 1 | 1 |
| Clear cell carcinoma | 2 | 4 |
| Other types | 9 | 14 |
| NAC | ||
| Yes | 47 | 21 |
| No | 25 | 49 |
| Residual disease | ||
| 0 | 5 | 19 |
| < 1 cm | 31 | 31 |
| ≥ 1 cm | 36 | 20 |
| Median TTR (months) | 3 | 30 |
NAC: Neoadjuvant chemotherapy; TTR: time to recurrence.